Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105315286A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel ruthenium-catalyzed asymmetric hydrogenation improves yield and purity for sitagliptin intermediates ensuring cost reduction and supply chain reliability for pharmaceutical manufacturing.